[1] |
World Health Organization. Global Health Estimates: Life expectancy and leading causes of death and disability[EB/OL].
URL
|
[2] |
Institute for Health Metrics and Evaluation. Global burden of disease 2019: Lower respiratory infections--Level 3 cause[EB/OL].
URL
|
[3] |
Ruan Z, Qi J, Qian ZM, et al. Disease burden and attributable risk factors of respiratory infections in China from 1990 to 2019[J]. Lancet Reg Health-West Pac,2021,11:100153.
|
[4] |
GBD 2015 LRI Collaborators. Estimates of the global, regional and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the global burden of disease study 2015[J]. Lancet Infect Dis,2017,17:1133-1161.
|
[5] |
GBD 2017 Influenza Collaborators. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017[J]. Lancet Respir Med,2019,7(1):69-89.
|
[6] |
Chaves SS, Aragon D, Bennett N, et al. Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype[J]. J Infect Dis,2013,208(8):1305-1314.
|
[7] |
Lafond KE, Porter RM, Whaley MJ, et al. Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: a systematic review and meta-analysis[J]. PLoS Med,2021,18(3):e1003550.
|
[8] |
Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study[J]. Lancet,2018,391(10127):1285-1300.
|
[9] |
World Health Organization. Fact sheets about tuberculosis[EB/OL]. (2021-10-14).
URL
|
[10] |
World Health Organization. Tuberculosis[EB/OL]. (2021-10-14)[2022-05-04].
URL
|
[11] |
World Health Organization. Global tuberculosis report 2021[R]. Geneva: World Health Organization,2021.
|
[12] |
曾瑜,杨晓妍,周海龙, 等. 中国人群结核病疾病负担的系统评价[J]. 中国循证医学杂志,2018,18(6):570-579.
|
[13] |
Wang H, Paulson KR, Pease SA, et al. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21[J]. Lancet,2022,399(10334):1513-1536.
|
[14] |
Mawaddah A, Gendeh HS, Lum SG, et al. Upper respiratory tract sampling in COVID-19[J]. Malays J Pathol,2020,42(1):23-35.
|
[15] |
Wang X, Tan L, Wang X, et al. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously[J]. Int J Infect Dis,2020,94:107-109.
|
[16] |
Patel MR, Carroll D, Ussery E, et al. Performance of oropharyngeal swab testing compared with nasopharyngeal swab testing for diagnosis of coronavirus disease 2019--United States, January 2020-February 2020[J]. Clin Infect Dis,2021,72(3):403-410.
|
[17] |
Wang H, Liu Q, Hu J, et al. Nasopharyngeal swabs are more sensitive than oropharyngeal swabs for COVID-19 diagnosis and monitoring the SARS-CoV-2 load[J]. Front Med (Lausanne),2020,7:334.
|
[18] |
Colagrossi L, Mattana G, Piccioni L, et al. Viral respiratory infections: New tools for a rapid diagnosis[J]. Semin Respir Crit Care Med,2021,42(6):747-758.
|
[19] |
World Health Organization. Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities[EB/OL].
URL
|
[20] |
Au WY, Cheung PPH. Diagnostic performances of common nucleic acid tests for SARS-CoV-2 in hospitals and clinics: a systematic review and meta-analysis[J]. Lancet Microbe,2021,2(12):e704-e714.
|
[21] |
Khandker SS, Hashim NHHN, Deris ZZ, et al. Diagnostic accuracy of rapid antigen test kits for detecting SARS-CoV-2: A systematic review and Meta-analysis of 17 171 suspected COVID-19 patients[J]. J Clin Med,2021,10(16):3493.
|
[22] |
Merckx J, Wali R, Schiller I, et al. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a systematic review and meta-analysis[J]. Ann Intern Med,2017,167:394-409.
|
[23] |
Uyeki TM. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues[J]. Clin Infect Dis,2009,49(2):279-290.
|
[24] |
World Health Organization. WHO recommendations on the use of rapid testing for influenza diagnosis[EB/OL]. 2012.
URL
|
[25] |
Gentilotti E, De Nardo P, Cremonini E, et al. Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis[J]. Clin Microbiol Infect,2022,28(1):13-22.
|
[26] |
Vos LM, Bruning AHL, Reitsma JB, et al. Rapid molecular tests for influenza, respiratory syncytial virus, and other respiratory viruses: A systematic review of diagnostic accuracy and clinical impact studies[J]. Clin Infect Dis,2019,69:1243.
|
[27] |
Steingart KR, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review[J]. Lancet Infect Dis,2006,6(9):570-581.
|
[28] |
Steingart KR, Schiller L, Horne DJ, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults[J]. Cochrane Database Syst Rev,2014,2014(1):CD00959.
|
[29] |
中华医学会结核病学分会. 结核分枝杆菌γ-干扰素释放试验及临床应用专家意见(2021年版)[J]. 中华结核和呼吸杂志,2022,45(2):143-150.
|
[30] |
Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis[J]. Chest,2010,137(4):952-968.
|
[31] |
Diel R, Goletti D, Ferrara G, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis[J]. Eur Respir J,2011,37(1):88-99.
|
[32] |
Santin M, Muñoz L, Rigau D. Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis[J]. PLoS One,2012,7(3):e32482.
|
[33] |
Kaplan JE, Benson C, Holmes KK, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America[J]. MMWR Recomm Rep,2009,58(RR-4):1-207; quiz CE1-4.
|
[34] |
Chanteau S, Rahalison L, Ralafiarisoa L, et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague[J]. Lancet,2003,361:211-216.
|
[35] |
张阳,王智群,邓世靖, 等. 涂片真菌荧光染色法对真菌性角膜炎诊断价值的研究[J]. 中华眼科杂志,2019,55(8):601-608.
|
[36] |
Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia[J]. Clin Infect Dis,2004,39(2):165-169.
|
[37] |
中华预防医学会医院感染控制分会. 临床微生物标本采集和送检指南[J]. 中华医院感染学杂志,2018,28(20):3194-3195.
|
[38] |
徐英春,倪语星,王金良. 血培养操作规范[M]. 上海: 上海科学技术出版社,2002:1-31.
|
[39] |
叶应妩主编. 全国临床检验操作规程[M]. 3版. 南京: 东南大学出版社,2006.
|
[40] |
王辉,任健康,王明贵. 临床微生物学检验[M]. 北京: 人民卫生出版社,2015.
|
[41] |
GB/T 22576.6-2021.《医学实验室质量和能力要求》[S]. 2021.
|
[42] |
Clinical and Laboratory Standards Institue. Quality control for commercially prepared microbiological culture media, 3rd Edition: CLSI M22 A3[S]. 2004.
|
[43] |
《中华传染病杂志》编辑委员会. 中国宏基因组学第二代测序技术检测感染病原体的临床应用专家共识[J]. 中华传染病杂志,2020,38(11):681-689.
|
[44] |
中华医学会检验医学分会临床微生物学组,中华医学会微生物学与免疫学分会临床微生物学组,中国医疗保健国际交流促进会临床微生物与感染分会. 宏基因组高通量测序技术应用于感染性疾病病原检测中国专家共识[J]. 中华检验医学杂志,2021,44(2):107-120.
|
[45] |
Schlaberg R, Chiu CY, Miller S, et al. Validation of metagenomic next-generation sequencing tests for universal pathogen detection[J]. Arch Pathol Lab Med,2017,141(6):776-786.
|
[46] |
宏基因组学测序技术在中重症感染中的临床应用共识专家组. 宏基因组学测序技术在中重症感染中的临床应用专家共识(第一版)[J]. 中华危重病急救医学,2020,32(5):531-536.
|
[47] |
中华医学会细菌感染与耐药防治分会. 呼吸系统感染中宏基因组测序技术临床应用与结果解读专家共识[J]. 中华临床感染病杂志,2022,15(2):90-102.
|
[48] |
Chiu CY, Miller SA. Clinical metagenomics[J]. Nat Rev Genet,2019,20(6):341-355.
|